Estimating HIV and HCV prevalence among people who inject drugs in 5 Ukrainian cities using stratification-based respondent driven and random sampling.

Background: Ukraine, a country of 45.5 million people, has one of the most volatile HIV and HCV epidemics in the world. In this paper, we estimate the prevalence of HIV and HCV among PWID in five Ukrainian cities.Methods: A cross-sectional study was conducted in 2014-2015, based on stratified hybrid...

Descripción completa

Detalles Bibliográficos
Publicado en:International Journal of Drug Policy Vol. 67; pp. 91 - 102
Autores principales: Zelenev, Alexei, Shea, Portia, Mazhnaya, Alyona, Meteliuk, Anna, Pykalo, Iryna, Marcus, Ruthanne, Fomenko, Tatiana, Prokhorova, Tatiana, Altice, Frederick L.
Formato: research tables/charts Journal Article
Publicado: Elsevier B.V. May2019
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=136088647&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 136088647
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        09553959
        GPD
      jtl: International Journal of Drug Policy
      issn: 09553959
      maglogo: N
    pubinfo:
      dt: May2019
      vid: 67
      pid: 467
      pub: Elsevier B.V.
      place: New York, New York
    artinfo:
      ui:
        136088647
        136088647
        NLM30503695
        136088647
        10.1016/j.drugpo.2018.09.010
        NLM30503695
        136088647
      ppf: 91
      ppct: 11
      formats:
      tig:
        atl: Estimating HIV and HCV prevalence among people who inject drugs in 5 Ukrainian cities using stratification-based respondent driven and random sampling.
      aug:
        au:
          Zelenev, Alexei
          Shea, Portia
          Mazhnaya, Alyona
          Meteliuk, Anna
          Pykalo, Iryna
          Marcus, Ruthanne
          Fomenko, Tatiana
          Prokhorova, Tatiana
          Altice, Frederick L.
        affil: Yale University School of Medicine, Section of Infectious Diseases, AIDS Program, New Haven, CT, 06510, USA
      sug:
        subj:
          Substance Abuse, Intravenous Epidemiology
          Hepatitis C Epidemiology
          HIV Infections Epidemiology
          Urban Areas
          Adult
          Comorbidity
          Female
          Young Adult
          Ukraine
          Male
          Cross Sectional Studies
          Prevalence
          Epidemiological Research
          Funding Source
          Human
          Adult: 19-44 years
          Female
          Male
      ab: Background: Ukraine, a country of 45.5 million people, has one of the most volatile HIV and HCV epidemics in the world. In this paper, we estimate the prevalence of HIV and HCV among PWID in five Ukrainian cities.Methods: A cross-sectional study was conducted in 2014-2015, based on stratified hybrid sampling with random and respondent driven sampling in five cities: Kyiv, Odesa, Mykolaiv, Dnipro and Lviv. Using data on HIV and HCV antibody testing from 1613 respondents, we evaluate selection bias in the sampling methods by analyzing spatial and network patterns of sampling processes. We develop and apply inverse probability weights in order to estimate the HIV and HCV prevalence in each city, as well as in the overall sample.Findings: The aggregate HIV prevalence for the five cities is 35.1% (95% CI: 29.5%-38.5%) but this varied considerably by city: in Kyiv the HIV prevalence is 26.6% (95% CI: 20.3.8%-33.4%), in Odesa - 38.2% (95% CI: 29.8% and 47.1%), in Mykolaiv - 42.0% (95% CI: 34.3%-49.2%), in Dnipro - 58.8% (95% CI: 52.2%-65.8%), and in Lviv 24.6% (95% CI: 18.8%-30.8%). The aggregate HCV prevalence estimate for the five cities is 58.6% (95% CI: 54.9%-61.7%). The highest HCV prevalence is estimated in Kyiv - 84.8% (95% CI: 78.5%-90.1%). HCV prevalence in Odesa is the lowest and estimated to be 36.5% (95% CI: 29.5%-45.1%), in Mykolaiv - 49.1% (95% CI: 41.5%-57.0%), in Dnipro - 56.1% (95% CI: 50.3%-63.4%) and in Lviv 38.5% (95% CI: 31.8%-45.0%).Conclusions: Monitoring behavioral and health outcomes of PWID on a regular basis is necessary for determining prevention and treatment priorities for HIV and HCV infections in Ukraine and elsewhere. The heterogeneity of the local epidemics provides insights into the best prevention and treatment strategies to be deployed in low-resource settings.
      pubtype: Academic Journal
      doctype:
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N